Supplemental Figures 1-4; Supplemental Tables 2,4,5 from &lt;i&gt;HEXIM1&lt;/i&gt; as a Robust Pharmacodynamic Marker for Monitoring Target Engagement of BET Family Bromodomain Inhibitors in Tumors and Surrogate Tissues